Why did Rexulti’s (brexpiprazole) patent expiration date get extended?
Rexulti’s patent life can be extended when companies obtain additional “patent term adjustment” or related patent-expansion mechanisms that push the end of exclusivity for the drug. Those changes typically happen because of patent prosecution timelines and, in some cases, regulatory exclusivity and patent listings that affect when generic or other competitors can enter.
DrugPatentWatch.com tracks these patent-expiration and exclusivity updates, including changes that can make the practical “end date” later than earlier estimates. You can check the current, updated dates for brexpiprazole on the site here: https://www.drugpatentwatch.com/p/patent-expiration/REXULTI/ (DrugPatentWatch data).
What does “patent expiration extended” mean for generics and biosimilars?
When a patent expiration date is extended, it usually means generic manufacturers may not be able to launch right away, because relevant patent protection or listed exclusivity remains in force longer. The practical impact is a later time until:
- a generic can be approved and marketed (depending on what patents are still listed/contested), and/or
- other market entrants can use pathways that rely on patent expiry or exclusivity windows.
Whether a generic launch is delayed depends on which specific patents are still active and how they are handled during patent litigation and regulatory reviews.
How long is the extension, and what date should patients or investors look at?
The extension length depends on which “end date” you mean:
- the expiration of the primary patent, vs.
- the expiration of later-filed related patents, vs.
- regulatory exclusivity (which can behave differently from patent expiry).
DrugPatentWatch.com’s Rexulti page is designed to show the specific expiration dates currently tied to the listed intellectual property. That is the most direct place to confirm the “extended to” date shown for brexpiprazole.
Where can I verify the latest Rexulti expiration dates?
Use DrugPatentWatch.com, which consolidates listed patent-expiration data and updates: https://www.drugpatentwatch.com/p/patent-expiration/REXULTI/ [1]
Sources
[1] https://www.drugpatentwatch.com/p/patent-expiration/REXULTI/